Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bourgier

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 6, 2023
Adjuvant breast radiotherapy in patients aged 65 and over: Not a binary decisionD Azria, C Bourgier, C Lemanski
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2018
[Modalities and advantages of image guided radiation therapy of breast cancer in adjuvant setting]E Kammerer, P Fenoglietto, C Bourgier
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2010
[Reirradiation of normal tissues: preclinical radiobiological data]C Bourgier, M-C Vozenin, E Deutsch
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2018
[The major debate: Micrometastases and breast cancer - To be for nodal irradiation]C Bourgier, C Lemanski, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 5, 2015
[Does nodal irradiation (clavicular and internal mammary chains) increase the toxicity of adjuvant breast radiotherapy?]O Riou, C Bourgier, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 24, 2012
[Radiobiology and breast cancer molecular classification: present or future?]C Bourgier, S Heymann, P Vielh, et al.
The British Journal of Radiology|August 22, 2007
Rho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicityV Haydont, C Bourgier, M-C Vozenin-Brotons
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 4, 2014
[New external radiotherapy technologies for breast cancer]A T Falk, P Fenoglietto, D Azria, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 4, 2015
[Impact of intensity-modulated radiotherapy on node irradiation for breast cancer]P Fenoglietto, C Bourgier, O Riou, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 8, 2015
[What type of hypofractionated radiotherapy of primary tumours in palliative care?]C Bourgier, M Charissoux, P Boisselier, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 6, 2023
Adjuvant breast radiotherapy in patients aged 65 and over: Not a binary decisionD Azria, C Bourgier, C Lemanski
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2018
[Modalities and advantages of image guided radiation therapy of breast cancer in adjuvant setting]E Kammerer, P Fenoglietto, C Bourgier
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 24, 2010
[Reirradiation of normal tissues: preclinical radiobiological data]C Bourgier, M-C Vozenin, E Deutsch
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 27, 2018
[The major debate: Micrometastases and breast cancer - To be for nodal irradiation]C Bourgier, C Lemanski, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 5, 2015
[Does nodal irradiation (clavicular and internal mammary chains) increase the toxicity of adjuvant breast radiotherapy?]O Riou, C Bourgier, P Fenoglietto, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 24, 2012
[Radiobiology and breast cancer molecular classification: present or future?]C Bourgier, S Heymann, P Vielh, et al.
The British Journal of Radiology|August 22, 2007
Rho/ROCK pathway as a molecular target for modulation of intestinal radiation-induced toxicityV Haydont, C Bourgier, M-C Vozenin-Brotons
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 4, 2014
[New external radiotherapy technologies for breast cancer]A T Falk, P Fenoglietto, D Azria, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 4, 2015
[Impact of intensity-modulated radiotherapy on node irradiation for breast cancer]P Fenoglietto, C Bourgier, O Riou, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 8, 2015
[What type of hypofractionated radiotherapy of primary tumours in palliative care?]C Bourgier, M Charissoux, P Boisselier, et al.
Pageof 7